Tomoe Shimazaki

878 total citations
21 papers, 449 citations indexed

About

Tomoe Shimazaki is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Tomoe Shimazaki has authored 21 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 7 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in Tomoe Shimazaki's work include Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (4 papers). Tomoe Shimazaki is often cited by papers focused on Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (4 papers). Tomoe Shimazaki collaborates with scholars based in Japan, United States and United Kingdom. Tomoe Shimazaki's co-authors include Kenichi Morikawa, Takuya Matsumura, Naoya Sakamoto, Michio Imawari, Takayoshi Ito, Kazumasa Hiroishi, Takuya Sho, Mitsuteru Natsuizaka, Osamu Maehara and Koji Ogawa and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Mutation research. Fundamental and molecular mechanisms of mutagenesis.

In The Last Decade

Tomoe Shimazaki

21 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoe Shimazaki Japan 10 220 170 97 95 73 21 449
Richard S. Hann United States 11 177 0.8× 191 1.1× 46 0.5× 95 1.0× 48 0.7× 13 389
Ahmed Eid Israel 9 200 0.9× 156 0.9× 56 0.6× 56 0.6× 29 0.4× 22 433
Hiroshige Kojima Japan 11 257 1.2× 275 1.6× 36 0.4× 158 1.7× 104 1.4× 22 552
Keara Towery United States 8 116 0.5× 132 0.8× 56 0.6× 64 0.7× 20 0.3× 8 336
A Tschuschner Germany 9 133 0.6× 142 0.8× 56 0.6× 90 0.9× 18 0.2× 16 421
Hong-Di Ma China 10 208 0.9× 171 1.0× 48 0.5× 66 0.7× 15 0.2× 12 386
Yiran Wei China 11 148 0.7× 182 1.1× 34 0.4× 77 0.8× 23 0.3× 27 393
Volker Meier Germany 8 231 1.1× 154 0.9× 49 0.5× 82 0.9× 27 0.4× 15 366
K Tanikawa Japan 9 181 0.8× 121 0.7× 52 0.5× 70 0.7× 17 0.2× 22 366
Wafaa M. Ezzat Egypt 13 191 0.9× 204 1.2× 27 0.3× 159 1.7× 19 0.3× 43 526

Countries citing papers authored by Tomoe Shimazaki

Since Specialization
Citations

This map shows the geographic impact of Tomoe Shimazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoe Shimazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoe Shimazaki more than expected).

Fields of papers citing papers by Tomoe Shimazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoe Shimazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoe Shimazaki. The network helps show where Tomoe Shimazaki may publish in the future.

Co-authorship network of co-authors of Tomoe Shimazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoe Shimazaki. A scholar is included among the top collaborators of Tomoe Shimazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoe Shimazaki. Tomoe Shimazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Furci, Leonardo, et al.. (2023). Long-read direct RNA sequencing reveals epigenetic regulation of chimeric gene-transposon transcripts in Arabidopsis thaliana. Nature Communications. 14(1). 3248–3248. 20 indexed citations
2.
Kawagishi, Naoki, Goki Suda, Megumi Kimura, et al.. (2020). High serum angiopoietin‐2 level predicts non‐regression of liver stiffness measurement‐based liver fibrosis stage after direct‐acting antiviral therapy for hepatitis C. Hepatology Research. 50(6). 671–681. 16 indexed citations
3.
Ohara, Masatsugu, Goki Suda, Megumi Kimura, et al.. (2020). Analysis of the optimal psoas muscle mass index cut‐off values, as measured by computed tomography, for the diagnosis of loss of skeletal muscle mass in Japanese people. Hepatology Research. 50(6). 715–725. 23 indexed citations
4.
Shigesawa, Taku, Goki Suda, Megumi Kimura, et al.. (2020). Baseline angiopoietin‐2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma. JGH Open. 4(5). 880–888. 9 indexed citations
5.
Ohara, Masatsugu, Goki Suda, Megumi Kimura, et al.. (2020). Computed tomography, not bioelectrical impedance analysis, is the proper method for evaluating changes in skeletal muscle mass in liver disease. SHILAP Revista de lepidopterología. 3(2). 103–114. 4 indexed citations
6.
Suda, Goki, Megumi Kimura, Taku Shigesawa, et al.. (2019). Effects of resistance‐associated variants in genotype 2 hepatitis C virus on viral replication and susceptibility to antihepatitis C virus drugs. Hepatology Research. 49(11). 1275–1285. 6 indexed citations
7.
Suzuki, Kazuharu, Goki Suda, Yoshiya Yamamoto, et al.. (2019). Entecavir treatment of hepatitis B virus‐infected patients with severe renal impairment and those on hemodialysis. Hepatology Research. 49(11). 1294–1304. 24 indexed citations
8.
Morikawa, Kenichi, Akihisa Nakamura, Tomoe Shimazaki, & Naoya Sakamoto. (2018). Safety and efficacy of elbasvir/grazoprevir for the treatment of chronic hepatitis C: current evidence. Drug Design Development and Therapy. Volume 12. 2749–2756. 4 indexed citations
9.
Sho, Takuya, Goki Suda, Megumi Kimura, et al.. (2018). Glecaprevir and Pibrentasvir for Japanese Patients with Human Immunodeficiency Virus and Genotype 3 Hepatitis C Virus Coinfection: A Report of Three Cases. Internal Medicine. 58(6). 797–802. 4 indexed citations
10.
11.
Morikawa, Kenichi, et al.. (2016). Hepatitis B: progress in understanding chronicity, the innate immune response, and cccDNA protection. Annals of Translational Medicine. 4(18). 337–337. 20 indexed citations
12.
Tsukuda, Yoko, Goki Suda, Seiji Tsunematsu, et al.. (2016). Anti-adipogenic and antiviral effects ofl-carnitine on hepatitis C virus infection. Journal of Medical Virology. 89(5). 857–866. 17 indexed citations
13.
Ito, Takayoshi, Kenichi Morikawa, Jun Arai, et al.. (2011). Lymphotropic hepatitis C virus has an interferon‐resistant phenotype. Journal of Viral Hepatitis. 19(4). 254–262. 9 indexed citations
14.
Ito, Takayoshi, et al.. (2010). Reactivation of epstein–barr virus in B cells of patients with chronic hepatitis C. Journal of Medical Virology. 82(12). 2064–2072. 5 indexed citations
15.
Hiroishi, Kazumasa, Junichi Eguchi, Toshiyuki Baba, et al.. (2009). Strong CD8+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma. Journal of Gastroenterology. 45(4). 451–458. 110 indexed citations
16.
Ito, Takayoshi, Kenichi Morikawa, Tomoe Shimazaki, et al.. (2009). Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C. Journal of Medical Virology. 81(4). 619–627. 35 indexed citations
17.
Doi, Hiroyoshi, Kazumasa Hiroishi, Tomoe Shimazaki, et al.. (2008). Magnitude of CD8+ T‐cell responses against hepatitis C virus and severity of hepatitis do not necessarily determine outcomes in acute hepatitis C virus infection. Hepatology Research. 39(3). 256–265. 5 indexed citations
18.
Nakamura, Akihiro, Tomoe Shimazaki, Kazuhiro Kaneko, et al.. (2002). Characterization of DNA polymorphisms in the E-cadherin gene (CDH1) promoter region. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 502(1-2). 19–24. 58 indexed citations
19.
Shimazaki, Tomoe, et al.. (1988). [Combination chemotherapy of adult T-cell leukemia (ATL) using cyclophosphamide, vindesine and prednisolone (CV'P)].. PubMed. 23(11). 2657–62. 3 indexed citations
20.
Shimada, Junichi, et al.. (1988). [Clinical significance of serum beta 2-microglobulin as a tumor marker of oral and maxillofacial malignant tumors].. PubMed. 17(2). 191–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard S. Hann Breakdown of academic impact, for papers by Ahmed Eid Breakdown of academic impact, for papers by Hiroshige Kojima Breakdown of academic impact, for papers by Keara Towery Breakdown of academic impact, for papers by A Tschuschner Breakdown of academic impact, for papers by Hong-Di Ma Breakdown of academic impact, for papers by Yiran Wei Breakdown of academic impact, for papers by Volker Meier Breakdown of academic impact, for papers by K Tanikawa Breakdown of academic impact, for papers by Wafaa M. Ezzat
Rankless by CCL
2026